Variability of serum concentrations of trimethoprim and sulfamethoxazole during high dose therapy
- 1 July 1993
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 21 (4), 206-209
- https://doi.org/10.1007/bf01728888
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patientsAIDS, 1992
- Adverse reactions to co-trimoxazole in HIV infectionThe Lancet, 1991
- Oral Therapy forPneumocystis cariniiPneumonia in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1990
- Can the course of high dose cotrimoxazole for Pneumocystis carinii pneumonia in AIDS be shorter? A possible solution to the problem of cotrimoxazole toxicityJournal of Internal Medicine, 1990
- Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumoniaAntimicrobial Agents and Chemotherapy, 1990
- MODIFIED TRIMETHOPRIM-SULPHAMETHOXAZOLE DOSES IN PNEUMOCYSTIS CARINII PNEUMONIAThe Lancet, 1987
- SERUM TRIMETHOPRIM AND SULPHAMETHOXAZOLE LEVELS IN AIDSThe Lancet, 1986
- Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meningesAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics of Intravenous Trimethoprim-Sulfamethoxazole in Children and Adults with Normal and Impaired Renal FunctionClinical Infectious Diseases, 1982
- Pharmacokinetics and Tolerance of a Single Twelve-Tablet Dose of Trimethoprim (960 mg)-Sulfamethoxazole (4,800 mg)Antimicrobial Agents and Chemotherapy, 1977